SS Innovations International (SSII) Change in Account Payables (2022 - 2026)
SS Innovations International (SSII) posted Change in Account Payables of -$704764.0 for Q1 2026, down 232.17% sequentially from $533226.0 in Q4 2025, and down 153.03% YoY from $1.3 million in Q1 2025.
SS Innovations International (SSII) Change in Account Payables (2022 - 2026) Analysis & Trends
SS Innovations International has reported Change in Account Payables for 5 years, with the latest figure at -$704764.0 in Q1 2026.
- Quarterly Change in Account Payables fell 153.03% year-over-year to -$704764.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $844018.0 (down 53.47% YoY) and the FY2025 annual result came in at $2.9 million, up 103.98% from the prior year.
- Change in Account Payables eased to -$704764.0 in Q1 2026 per SSII's latest filing, from $533226.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.5 million in Q2 2025 and troughed at -$1.4 million in Q3 2025.
- A 5-year average of $297829.7 and a median of $183201.0 in 2022 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables soared 11752.61% in 2024, then plunged 313.89% in 2025.
- Over 5 years, Change in Account Payables stood at $183201.0 in 2022, then decreased by 0.93% to $181498.0 in 2023, then soared by 183.07% to $513770.0 in 2024, then gained by 3.79% to $533226.0 in 2025, then slumped by 232.17% to -$704764.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$704764.0, $533226.0, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 4.30 Mn |
| 10 | SS Innovations International | 730.50 Mn | 708.20 Mn | 7.10 Mn | 832,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 832,492.00 |
| Jun 30, 2026 | 832,492.00 |
| Mar 31, 2026 | -704,764.00 |
| Mar 31, 2026 | -704,764.00 |
| Dec 31, 2025 | 533,226.00 |
| Dec 31, 2025 | 533,226.00 |
| Sep 30, 2025 | -1.44 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 513,770.00 |
| Dec 31, 2024 | 513,770.00 |
| Sep 30, 2024 | 672,239.00 |
| Sep 30, 2024 | 672,239.00 |
| Jun 30, 2024 | -701,262.00 |
| Jun 30, 2024 | -701,262.00 |
| Mar 31, 2024 | 926,083.00 |
| Mar 31, 2024 | 926,083.00 |